Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT07806422

Virtual Reality-based Sensory Stimulation for Delirium Prevention in Intensive Care Units

Conditions: Delirium in the Intensive Care Unit

Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: NA
Enrollment: 300
Sponsor: Chinese University of Hong Kong

Location: Southern Medical University Shenzhen Hospital, Peking University Shenzhen Hospital, Shenzhen People's Hospital Shenzhen Guangdong

Summary

The goal of this clinical trial is to evaluate whether virtual reality (VR)-based sensory stimulation can help prevent delirium in adult intensive care unit (ICU) patients, compared with an active control condition delivering the same nature-based audiovisual content via a tablet. The main questions it aims to answer are: 1. Does VR-based sensory stimulation delay the time to the first delirium event during ICU stay? 2. Does VR-based sensory stimulation reduce delirium incidence, duration, and severity? 3. What are the effects of the intervention on ICU length of stay, duration of mechanical ventilation, cognitive function at 3 months after ICU discharge, and health-related quality of life? Researchers will compare immersive VR-based sensory stimulation with a non-immersive tablet-based active control to assess the added value of immersion beyond the effects of sensory content alone. Participants will: 1. Receive either immersive VR-based sensory stimulation or tablet-based sensory stimulation 2. Receive one 20-minute session per day for up to 3 days during ICU stay Undergo twice-daily delirium assessments during ICU stay Complete follow-up assessments of cognitive function and health-related quality of life at 3 months after ICU discharge

Eligibility Criteria

Inclusion Criteria: * Age 18 years or older * Admitted to the ICU * Undergoing or expected to require mechanical ventilation * Expected ICU stay of at least 48 hours * Awake or lightly sedated, defined as a Richmond Agitation-Sedation Scale - (RASS) score between -1 and +1 * Able to understand and follow instructions * Provided informed consent \[or surrogate consent, if applicable\] Exclusion Criteria: * Pre-existing cognitive impairment or dementia * Acute psychiatric illness at admission * Delirium at enrollment as assessed by CAM-ICU * Terminal-stage cancer * APACHE II score \> 20 * Severe uncorrectable hearing or visual impairment * Traumatic brain injury or intracranial drainage tubes that make use of the VR headset impractical

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07806422). StuddyBuddy aggregates publicly available trial information.